Pathogenesis and treatment of immune-mediated neuropathies.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed.

1. Genetic risk of chronic pain conditions associated with risk of suicide death through an integrative analysis of EHR and genomics data.Translational psychiatry · 2026
   Article
2. Management of Severe Pain in a Case of Sensory Guillain-Barre Syndrome.Cureus · 2024
   Article
3. Kinesin-5 inhibition improves neural regeneration in experimental autoimmune neuritis.Journal of neuroinflammation · 2023
   Article
4. Principles of Therapeutic Apheresis in Neurological Disease.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
   Review
5. Nerve Imaging, Electrodiagnostics, and Clinical Examination - Three Musketeers to Differentiate Polyneuropathies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
   Article
6. Dysregulation of lncRNAs in autoimmune neuropathies.Scientific reports · 2021
   Article
7. Over-Expression of Immune-Related lncRNAs in Inflammatory Demyelinating Polyradiculoneuropathies.Journal of molecular neuroscience : MN · 2021
   Article
8. Assessment of Expression ofFrontiers in immunology · 2021
   Article
9. Guillain-Barré Syndrome in a Patient with Sickle Cell Anemia.HCA healthcare journal of medicine · 2021
   Article
10. High Levels of Il-19 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy.Journal of molecular neuroscience : MN · 2020
    Article
11. Assessment of IL-38 Levels in Patients with Acquired Immune-Mediated Polyneuropathies.Journal of molecular neuroscience : MN · 2020
    Article
12. The effectiveness and safety of acupuncture therapy for Guillain-Barré syndrome: A systematic review and meta-analysis protocol.Medicine · 2020
    Article
13. Acute flaccid myelitis associated with enterovirus D68 in a non-epidemic setting.IDCases · 2019
    Article
14. Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and Beyond.CNS drugs · 2018
    Review
15. Associated conditions in small fiber neuropathy - a large cohort study and review of the literature.European journal of neurology · 2018
    Review
16. Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia.Case reports in hematology · 2017
    Article
17. Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP).Journal of neuroinflammation · 2016
    Article
18. [Differential diagnostics of diseases of the brachial plexus].Der Nervenarzt · 2014
    Review
19. Neurofascin as a target for autoantibodies in peripheral neuropathies.Neurology · 2012
    Article
20. Treatment-related Fluctuations in Guillain Barre Syndrome and the Conundrum of Additional Cycles of Plasmapheresis.Annals of Indian Academy of Neurology
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as